[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  MERCK Kommanditgesellschaft auf Aktien MERCK stock sees mixed signals as positive analyst recommendations and a potential drug price deal offer support, but negative trial results for Xevinapant weigh on gains. ### About MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien (MRKDE) is a pharmaceutical and chemical company. ### Insights [#](/topic/$mrkde/insights) - MERCK Kommanditgesellschaft auf Aktien engagements is up XXXXXXXX% from the previous week. ### Price: $ [#](/topic/$mrkde/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/close.tsv) The price action is likely influenced by positive news regarding the White House's drug-buying site and analyst recommendations, potentially leading to an increase in stock value. However, the negative trial results for Xevinapant could temper the gains. **1-Year High**: $XXX on 2024-10-23 **1-Year Low**: $XXXXXX on 2025-08-07 ### AltRank: undefined [#](/topic/$mrkde/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/alt_rank.tsv) MERCK Kommanditgesellschaft auf Aktien is currently AltRank #undefined based on combined combined social and market metrics **Daily Average**: XXX **1-Year High**: XXX on 2025-04-01 **1-Year Low**: XXX on 2025-03-07 ### Galaxy Score: XX [#](/topic/$mrkde/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XX on 2025-03-03 **1-Year Low**: XX on 2025-03-23 ### Engagements: XX [#](/topic/$mrkde/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Week**: XXX +3,513% **1 Month**: XXX +48% **6 Months**: XXXXXX -XX% **1 Year**: XXXXXXX +1,402% **1-Year High**: XXXXXX on 2025-03-06 **1-Year Low**: X on 2024-11-03 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$mrkde/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X +300% **6 Months**: XX -XX% **1 Year**: XX +347% **1-Year High**: XX on 2025-03-05 **1-Year Low**: X on 2024-10-29 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$mrkde/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/contributors_active.tsv) X unique social accounts have posts mentioning MERCK Kommanditgesellschaft auf Aktien in the last XX hours which is up XX% from X in the previous XX hours **Daily Average**: X **1 Month**: X +300% **6 Months**: XX -XX% **1 Year**: XX +283% **1-Year High**: XX on 2025-03-05 **1-Year Low**: X on 2024-10-29 ### Market Cap: $undefined [#](/topic/$mrkde/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/market_cap.tsv) **Current Value**: $undefined **Daily Average**: $XXXXXXXXXXXXXX **1-Year High**: $XXXXXXXXXXXXXX on 2024-10-23 **1-Year Low**: $XXXXXXXXXXXXXX on 2025-03-27 **Top assets mentioned** In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours [Merck & Co., Inc. (MRK)](/topic/$mrk) [GSK plc (GSK)](/topic/$gsk) [Novartis AG (NVS)](/topic/$nvs) [Synthetify (SNY)](/topic/$sny) [GSK plc (GSK)](/topic/gsk-plc) [Sanofi (SNY)](/topic/sanofi) [Pfizer, Inc. (PFE)](/topic/$pfe) [AstraZeneca PLC (AZN)](/topic/$azn) **Top topics mentioned** In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [investment](/topic/investment), [$mrk](/topic/$mrk), [manat](/topic/manat), [$gsk](/topic/$gsk), [$nvs](/topic/$nvs), [donald trump](/topic/donald-trump), [$sny](/topic/$sny), [$rhhby](/topic/$rhhby), [gsk plc](/topic/gsk-plc), [sanofi](/topic/sanofi), [tariffs](/topic/tariffs), [$pfe](/topic/$pfe), [$azn](/topic/$azn) ### Top Social Posts [#](/topic/$mrkde/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Merck KGaA stating a drug has near half-blockbuster potential One of the funnier things Ive seen in an investor presentation $MRK.DE" [X Link](https://x.com/occams_tooth/status/1978949899279302929) [@occams_tooth](/creator/x/occams_tooth) 2025-10-16T22:23Z XXX followers, XXX engagements "Pharma pops off Premarket: $AZN +7% $RHHBY +6.7% $SNY +4.8% after $PFE clinches US drug price deal winning a 3Y tariff grace period under Trump plan. Street sees blueprint for peers $NVS $MRK.DE $GSK in talks with US to avoid XXX% drug import tariffs" [X Link](https://x.com/schaeffers/status/1973377220258238741) [@schaeffers](/creator/x/schaeffers) 2025-10-01T13:19Z 11.6K followers, XXX engagements "Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA" [X Link](https://x.com/med__twi/status/1966952678518673568) [@med__twi](/creator/x/med__twi) 2025-09-13T19:50Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
MERCK stock sees mixed signals as positive analyst recommendations and a potential drug price deal offer support, but negative trial results for Xevinapant weigh on gains.
MERCK Kommanditgesellschaft auf Aktien (MRKDE) is a pharmaceutical and chemical company.
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by positive news regarding the White House's drug-buying site and analyst recommendations, potentially leading to an increase in stock value. However, the negative trial results for Xevinapant could temper the gains.
1-Year High: $XXX on 2024-10-23
1-Year Low: $XXXXXX on 2025-08-07
AltRank 24-Hour Time-Series Raw Data
MERCK Kommanditgesellschaft auf Aktien is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXX on 2025-04-01
1-Year Low: XXX on 2025-03-07
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-03-23
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +3,513%
1 Month: XXX +48%
6 Months: XXXXXX -XX%
1 Year: XXXXXXX +1,402%
1-Year High: XXXXXX on 2025-03-06
1-Year Low: X on 2024-11-03
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X +300%
6 Months: XX -XX%
1 Year: XX +347%
1-Year High: XX on 2025-03-05
1-Year Low: X on 2024-10-29
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning MERCK Kommanditgesellschaft auf Aktien in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1 Month: X +300%
6 Months: XX -XX%
1 Year: XX +283%
1-Year High: XX on 2025-03-05
1-Year Low: X on 2024-10-29
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXX on 2024-10-23
1-Year Low: $XXXXXXXXXXXXXX on 2025-03-27
Top assets mentioned In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours
Merck & Co., Inc. (MRK) GSK plc (GSK) Novartis AG (NVS) Synthetify (SNY) GSK plc (GSK) Sanofi (SNY) Pfizer, Inc. (PFE) AstraZeneca PLC (AZN)
Top topics mentioned In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours
stocks healthcare, investment, $mrk, manat, $gsk, $nvs, donald trump, $sny, $rhhby, gsk plc, sanofi, tariffs, $pfe, $azn
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Merck KGaA stating a drug has near half-blockbuster potential One of the funnier things Ive seen in an investor presentation $MRK.DE"
X Link @occams_tooth 2025-10-16T22:23Z XXX followers, XXX engagements
"Pharma pops off Premarket: $AZN +7% $RHHBY +6.7% $SNY +4.8% after $PFE clinches US drug price deal winning a 3Y tariff grace period under Trump plan. Street sees blueprint for peers $NVS $MRK.DE $GSK in talks with US to avoid XXX% drug import tariffs"
X Link @schaeffers 2025-10-01T13:19Z 11.6K followers, XXX engagements
"Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA"
X Link @med__twi 2025-09-13T19:50Z XXX followers, XXX engagements
/topic/$mrkde